Cargando…

Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A(2A) Receptor Antagonists

[Image: see text] Due to its double bond, istradefylline rapidly isomerizes to Z-istradefylline when exposed to normal daylight in dilute solution. To solve the poor photostability of the istradefylline solution, a series of istradefylline derivatives (in total 17 compounds, including II-1 and II-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yiyun, Xu, Haojie, Wang, Hongyi, Zheng, Zhonghui, Meng, Zihui, Xu, Zhibin, Li, Jiarong, Xue, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906590/
https://www.ncbi.nlm.nih.gov/pubmed/33644551
http://dx.doi.org/10.1021/acsomega.0c05741
_version_ 1783655321698304000
author Wang, Yiyun
Xu, Haojie
Wang, Hongyi
Zheng, Zhonghui
Meng, Zihui
Xu, Zhibin
Li, Jiarong
Xue, Min
author_facet Wang, Yiyun
Xu, Haojie
Wang, Hongyi
Zheng, Zhonghui
Meng, Zihui
Xu, Zhibin
Li, Jiarong
Xue, Min
author_sort Wang, Yiyun
collection PubMed
description [Image: see text] Due to its double bond, istradefylline rapidly isomerizes to Z-istradefylline when exposed to normal daylight in dilute solution. To solve the poor photostability of the istradefylline solution, a series of istradefylline derivatives (in total 17 compounds, including II-1 and II-2 series) were designed and synthesized, and their biological activity in inhibiting cAMP was evaluated. The IC(50) values of compounds II-1-3, II-2-1, II-2-2, II-2-3, II-2-4, and II-2-6 were 7.71, 6.52, 6.16, 7.23, 7.96, and 9.68 μg/mL, respectively, which had the same order of activity as that of istradefylline (IC(50) value was 1.94 μg/mL). The preliminary structure–activity relationship suggested that the 6-amino in adenine played an important role in binding an A(2A) receptor. The results of photostability experiments showed that the photostability of the target compounds of II-1 and II-2 series was improved when compared with that of istradefylline.
format Online
Article
Text
id pubmed-7906590
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-79065902021-02-26 Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A(2A) Receptor Antagonists Wang, Yiyun Xu, Haojie Wang, Hongyi Zheng, Zhonghui Meng, Zihui Xu, Zhibin Li, Jiarong Xue, Min ACS Omega [Image: see text] Due to its double bond, istradefylline rapidly isomerizes to Z-istradefylline when exposed to normal daylight in dilute solution. To solve the poor photostability of the istradefylline solution, a series of istradefylline derivatives (in total 17 compounds, including II-1 and II-2 series) were designed and synthesized, and their biological activity in inhibiting cAMP was evaluated. The IC(50) values of compounds II-1-3, II-2-1, II-2-2, II-2-3, II-2-4, and II-2-6 were 7.71, 6.52, 6.16, 7.23, 7.96, and 9.68 μg/mL, respectively, which had the same order of activity as that of istradefylline (IC(50) value was 1.94 μg/mL). The preliminary structure–activity relationship suggested that the 6-amino in adenine played an important role in binding an A(2A) receptor. The results of photostability experiments showed that the photostability of the target compounds of II-1 and II-2 series was improved when compared with that of istradefylline. American Chemical Society 2021-02-04 /pmc/articles/PMC7906590/ /pubmed/33644551 http://dx.doi.org/10.1021/acsomega.0c05741 Text en © 2021 The Authors. Published by American Chemical Society This is an open access article published under an ACS AuthorChoice License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Wang, Yiyun
Xu, Haojie
Wang, Hongyi
Zheng, Zhonghui
Meng, Zihui
Xu, Zhibin
Li, Jiarong
Xue, Min
Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A(2A) Receptor Antagonists
title Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A(2A) Receptor Antagonists
title_full Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A(2A) Receptor Antagonists
title_fullStr Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A(2A) Receptor Antagonists
title_full_unstemmed Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A(2A) Receptor Antagonists
title_short Design, Synthesis, and Biological Activity Studies of Istradefylline Derivatives Based on Adenine as A(2A) Receptor Antagonists
title_sort design, synthesis, and biological activity studies of istradefylline derivatives based on adenine as a(2a) receptor antagonists
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906590/
https://www.ncbi.nlm.nih.gov/pubmed/33644551
http://dx.doi.org/10.1021/acsomega.0c05741
work_keys_str_mv AT wangyiyun designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists
AT xuhaojie designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists
AT wanghongyi designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists
AT zhengzhonghui designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists
AT mengzihui designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists
AT xuzhibin designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists
AT lijiarong designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists
AT xuemin designsynthesisandbiologicalactivitystudiesofistradefyllinederivativesbasedonadenineasa2areceptorantagonists